Ipsen and Sutro Biopharma entered a global licensing deal for STRO-003, an ADC targeting ROR1, overexpressed in cancers, ...

The company also offers syngeneic cell line for immunization and screening; peptide production for subsequent antibody discovery campaign; B cell select platform, which allows for the ...

No writing assistance was utilized in the production of this manuscript ... efficacy and between the agents themselves. Antibodies against B cells Rituximab is a depleting antibody directed ...

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

Learn more about whether AbbVie Inc. or Genmab A/S is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Salmon, sardines, UV-exposed mushrooms, fortified milks and eggs are some food sources of vitamin D. If you don’t regularly ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

All three were hooked up to machines that provided a readout of their vital signs, and all three were prepared to have a syringe of manufactured blood injected into their veins. There were, of course, ...

Q4 2024 Earnings Conference Call January 29, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP of IRRainer Blair ...